InterShunt Technologies has initiated the EASE HF2 early feasibility study to assess the InterShunt percutaneous atrial shunt ...

ATTR-CM (transthyretin amyloid cardiomyopathy) is a rare condition that causes a range of vague symptoms, including shortness ...

Heart attack symptoms in women differ significantly from men's, leading to delayed diagnosis and poorer outcomes. Experts ...

The FDA has updated labels on the top two COVID-19 vaccines to warn of a rare heart side effect, mostly seen in young men.

InterShunt Technologies announced today that it began an early feasibility study of its device for reducing heart failure symptoms.

Dr. Mark Vessely from Mercy Medical Center joins Jenyne for a conversation about atrial fibrillation for 'AFib.' ...

Hemotag, from Boca Raton-based Aventusoft, is applied to the chest and captures vibrations from three locations that assess valve signatures, cardiac pressure, and function. It provides a real-time ...

Death rates from high blood pressure, arrhythmias and heart failure have risen sharply since 1970, new research shows.

June is Men’s Health Month and a perfect time for men to think about and act on ways to better their heart health. Heart ...

Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.